Autoantibodies May Drive Neurological Symptoms in a Subset of Long COVID Patients
TL;DR
A NIH-funded study found autoantibodies that target the nervous system are present in some Long COVID patients and may be linked to neurological symptoms; experiments transferring these antibodies to mice reproduced pain sensitivity, balance issues, and fatigue, suggesting autoimmunity could underlie a subset of Long COVID symptoms and might guide targeted therapies, though more research is needed to map specific antibodies and confirm causality.
- Immune system may attack nervous system in some Long COVID patients National Institutes of Health (.gov)
- Blood antibody levels could clarify long COVID prognosis and memory problems Medical Xpress
- Pathological potential of autoantibodies in long COVID Nature
Want the full story? Read the original reporting
Read on National Institutes of Health (.gov)